This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Inhibition on Platelet Aggregation
and you are
between 18 and 50
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Study to see if platelet transfusion stop or lessen the effect of the drug on platelets

Provided treatments

  • Drug: Ticagrelor
  • Drug: Clopidogrel
  • Drug: ASA

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01744288. The sponsor of the trial is AstraZeneca and it is looking for 258 volunteers for the current phase.
Official trial title:
A Open Label, Randomized, Crossover and Potential Parallel, Single Dose Study of Ticagrelor 180 mg and Acetylsalicylic Acid (ASA) in Healthy Volunteers Followed by Autologous in Vivo Platelet Transfusion to Determine the Effects of Platelet Supplementation on the Reversibility of Platelet Inhibition